0
Catabasis Pharmaceuticals, Inc. has reached its limit for free report views
Work for Catabasis Pharmaceuticals, Inc.? Upgrade Your Profile and unlock all your annual reports.
Catabasis Pharmaceuticals, Inc.
- 11-50 Employees
- Based in Boston, Massachusetts
At Catabasis Pharmaceuticals, their mission is to bring hope and life-changing therapies to patients and their families. Their lead program is edasalonexent, an NF-kB inhibitor in Phase 3 development for the treatment of Duchenne muscular dystrophy.
Catabasis Pharmaceuticals, Inc.
Most Recent Annual Report
MOST RECENT
2019 Annual Report and Form 10K
Report Locked. Catabasis Pharmaceuticals, Inc. has reached its limit for free report views.
